Raymond James Reiterates Buy Rating on UBSI

On July 1, 2026, Raymond James reiterated its buy rating on UBSI, setting a price target of $50. Analyst Steve Moss confirmed this stance, indicating continued confidence in the stock's potential. UBSI shares were trading at $45.83 on Wednesday, showing steady interest from investors.

Other Institutional Activity in UBSI

Several major funds have recently adjusted their holdings in UBSI. BlackRock, Inc. increased its stake by 86,459 shares, bringing its total to 20,166,538 shares valued at approximately $835.3 million, marking a modest 0.4% increase. State Street Corp also raised its holdings by 24,991 shares to a total of 7,974,217 shares, worth about $333.2 million, reflecting a 0.3% increase. Meanwhile, Dimensional Fund Advisors LP added 56,808 shares, growing its position by 0.7% to 7,661,331 shares, valued at $317.3 million. Vanguard Portfolio Management LLC and Vanguard Capital Management LLC both opened new positions, acquiring 7,277,538 and 6,344,890 shares respectively, valued at $301.4 million and $262.8 million. Conversely, Earnest Partners LLC reduced its stake by 105,625 shares, now holding 4,134,503 shares, valued at $171.3 million, a 2.5% decrease.

Insider Buying and Selling at United Bankshares, Inc.

Recent insider activity shows Clinton Winter actively purchasing shares of UBSI. On July 1, 2026, Winter bought 470 shares at an average price of $46.37. Previously, on June 1, he acquired 7 shares at $42.31, and on May 15, he purchased 744 shares at $42.06. Winter has consistently bought shares over the past months, with purchases also recorded on April 1, March 4, and February 25, at prices ranging from $41.70 to $42.54.

Analysts Set New Price Targets

Raymond James maintained its buy rating on UBSI with a $50 price target on July 1, 2026. On June 24, 2026, Hovde Group initiated coverage on the stock with a hold rating and a $49 price target. Earlier in the year, Keefe, Bruyette & Woods and Stephens & Co. maintained their hold ratings, with targets of $43 and $44, respectively. Piper Sandler had upgraded the stock to a buy with a target of $42.5 back in October 2025.

Bottom Line

Raymond James' reiteration of its buy rating on UBSI with a $50 target highlights the firm's confidence in the stock's future performance. Institutional investors are making varied moves, with some increasing their stakes and others reducing. Insider buying by Clinton Winter suggests internal confidence in UBSI. As always, remember that analyst ratings and institutional moves are backward-looking and should be considered as part of a broader investment strategy.